LGR4 and neoplasm: MiR-449b as a tumor suppressor prevented the proliferation of NSCLC by downregulating LGR4 (Yang et al., 2018) and LGR4 was perceived as a high-risk immune gene in NSCLC (Sun et al., 2020).